External Funding » Cancer Center » UF Health Cancer Center

Updated: October 2020

Coming Soon

Centers for Disease Control and Prevention (CDC)
Reducing Inequities in Cancer Outcomes through Community-Based Interventions on Social Determinants of Health

Featured cancer-focused external funding opportunities:

Sponsor	Title	Due Date	Category	Type
Melanoma Research Alliance (MRA)	Melanoma Research Alliance and St. Baldrick’s Foundation: Young Investigator Awards in Pediatric Melanoma	10/21/2020	Non-Limited	Research
National Institutes of Health (NIH)	Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)	10/21/2020	Non-Limited	Research
National Institutes of Health (NIH)	Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)	10/21/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (P50 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (U01 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (R01 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (U54 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications for Mechanisms of Cancer Drug Resistance (P01 Clinical Trial Not Allowed)	10/22/2020	Non-Limited	Research
National Institutes of Health (NIH)	Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)	10/27/2020 02/17/2021	Non-Limited	Research
Pfizer	Pfizer: Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer	10/29/2020	Non-Limited	Research
American Society of Clinical Oncology (ASCO)	American Society of Clinical Oncology (ASCO): 2021 Conquer Cancer – Breast Cancer Research Foundation® Career Development Award (CDA) for Diversity, Inclusion and Breast Cancer Disparities	10/29/2020	Non-Limited	Research
American Society of Clinical Oncology (ASCO)	American Society of Clinical Oncology (ASCO): 2021 Conquer Cancer – Breast Cancer Research Foundation® Young Investigator Awards for Diversity, Inclusion and Breast Cancer Disparities	10/29/2020	Non-Limited	Training/Career
Pfizer	Pfizer: NSCLC Oncogene Driver Considerations in Testing & Treatment	10/29/2020	Non-Limited	Research
National Institutes of Health (NIH)	Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)	10/30/2020	Non-Limited	Research
Cancer Research Institute (CRI)	Cancer Research Institute: Clinic & Laboratory Integration Program (CLIP)	11/01/2020	Non-Limited	Research
Pfizer	Pfizer: Biosimilars in Hematologic Malignancies & Supportive Care	11/02/2020	Non-Limited	Research
Pfizer	Pfizer: Metastatic Breast Cancer Patient Education: Navigating Treatment & Decision Making	11/02/2020	Non-Limited	Research
National Institutes of Health (NIH)	Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)	11/04/2020	Non-Limited	Research
Melanoma Research Alliance (MRA)	Melanoma Research Alliance and St. Baldrick’s Foundation: Young Investigator Awards in Pediatric Melanoma	11/04/2020	Non-Limited	Research
Melanoma Research Alliance (MRA)	Melanoma Research Alliance: 2020-2021 Request for Proposals Second Release	11/04/2020	Non-Limited	Research
National Institutes of Health (NIH)	Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)	11/06/2020	Non-Limited	Research
National Institutes of Health (NIH)	Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)	11/06/2020	Non-Limited	Research
National Institutes of Health (NIH)	Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)	11/06/2020	Non-Limited	Research
National Institutes of Health (NIH)	Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)	11/06/2020	Non-Limited	Research
National Cancer Institute (NCI)	NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)	11/09/2020	Non-Limited	Research
National Cancer Institute (NCI)	NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)	11/09/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Rare Cancers, Idea Development Award	11/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed)	11/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)	11/12/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Rare Cancers, Resource and Community Development Award	11/12/2020	Non-Limited	Research
Department of Defense (DOD)	DoD Rare Cancers, Concept Award	11/12/2020	Non-Limited	Research
National Institutes of Health (NIH)	Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)	11/13/2020	Non-Limited	Research
Cancer Research Institute (CRI)	Cancer Research Institute: Technology Impact Award	11/15/2020	Non-Limited	Research
National Institutes of Health (NIH)	Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)	11/15/2020	Non-Limited	Research
National Cancer Institute (NCI)	Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)	11/17/2020	Non-Limited	Research
National Cancer Institute (NCI)	Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)	11/17/2020	Non-Limited	Research
National Institutes of Health (NIH)	Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)	11/17/2020	Non-Limited	Research
National Institutes of Health (NIH)	Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)	11/18/2020	Non-Limited	Research
National Institutes of Health (NIH)	Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)	11/19/2020	Non-Limited	Research
St. Baldrick's Foundation	St. Baldrick's Foundation Spring 2021 Grant Cycle	11/20/2020	Limited	Research
Pfizer	Pfizer: Prostate Cancer Disparities Project	12/01/2020	Non-Limited	Research
DKMS (DKMS)	DKMS Stiftung Leben Spenden (Foundation for Giving Life): John Hansen Research Grant	12/08/2020	Non-Limited	Research
American Lung Association (ALA)	American Lung Association: Allergic Respiratory Diseases Award	12/10/2020	Non-Limited	Research
National Institutes of Health (NIH)	Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)	12/10/2020	Non-Limited	Research
Damon Runyon Cancer Research Foundation	2021 Damon Runyon Clinical Investigator Award	12/11/2020	Limited	Research
National Institutes of Health (NIH)	Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)	12/15/2020	Non-Limited	Research
Alexs Lemonade Stand Foundation (ALSF)	Alex’s Lemonade Stand Foundation (ALSF) and RUNX1 Research Program (RRP) Early Career Investigator Grant	12/16/2020	Non-Limited	Research
National Cancer Institute (NCI)	NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)	12/18/2020	Non-Limited	Research
Elsa U. Pardee Foundation	Cancer Research Grants	12/31/2020	Non-Limited	Research
National Cancer Institute (NCI)	NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)	01/04/2021	Non-Limited	Research
National Cancer Institute (NCI)	National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)	01/07/2021	Non-Limited	Research
National Institutes of Health (NIH)	Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)	01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)	01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)	01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required)	01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)	01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)	01/07/2021	Non-Limited	Research
National Institutes of Health (NIH)	Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)	01/07/2021	Non-Limited	Training/Career
National Institutes of Health (NIH)	Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)	01/07/2021 02/12/2021	Non-Limited	Research
National Institutes of Health (NIH)	Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)	01/07/2021 02/12/2021	Non-Limited	Research
National Institutes of Health (NIH)	Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)	01/07/2021 02/12/2021	Non-Limited	Research
American Society of Clinical Oncology (ASCO)	American Society of Clinical Oncology (ASCO): Long-Term International Fellowship (LIFe)	01/14/2021	Non-Limited	Training/Career
Cancer Research Institute (CRI)	Cancer Research Institute: Lloyd J. Old STAR Program	01/15/2021	Non-Limited	Research
National Institutes of Health (NIH)	Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)	01/20/2021	Non-Limited	Research
National Institutes of Health (NIH)	Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required)	01/25/2021 05/25/2021	Non-Limited	Research
National Cancer Institute (NCI)	NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)	01/07/2021	Non-Limited	Research
National Institutes of Health (NIH)	Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)	02/05/2021	Non-Limited	Research
National Institutes of Health (NIH)	Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)	02/05/2021	Non-Limited	Research
National Institutes of Health (NIH)	Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)	02/11/2021	Non-Limited	Research
National Institutes of Health (NIH)	Co-infection and Cancer (R21 Clinical Trial Not Allowed)	02/16/2021	Non-Limited	Research
National Institutes of Health (NIH)	Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)	02/16/2021	Non-Limited	Research
National Institutes of Health (NIH)	Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)	02/18/2021	Non-Limited	Research
National Institutes of Health (NIH)	Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)	02/18/2021	Non-Limited	Research
Mark Foundation for Cancer Research (MARK FOU F)	Mark Foundation Endeavor Awards	03/01/2021	Non-Limited	Research
National Institutes of Health (NIH)	Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)	03/15/2021	Non-Limited	Research
B*Cured	Brain Cancer Research Investigator Grant	04/01/2021	Non-Limited	Research
National Cancer Institute (NCI)	Metastasis Research Network (U54 Clinical Trial Not Allowed)	05/28/2021	Non-Limited	Research
National Institutes of Health (NIH)	Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)	06/17/2021	Non-Limited	Research